1 Guru Nanak College of Paramedical Sciences and Hospital, Jhajra, Dehradun, Uttarakhand, India
2 Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand, India
3 Teerthanker Mahaveer University, Moradabad , India
Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by bradykinesia, rigidity, tremors, and postural instability, leading to substantial impairments in mobility, balance, and daily functioning. Physical therapy plays a key role in managing PD; however, conventional approaches may lack individualized guidance and continuous feedback. Recent technological advancements have introduced artificial intelligence (AI)–powered physical therapy systems, offering adaptive, personalized, and data-driven rehabilitation programs. This study evaluates the effectiveness of AI-assisted physical therapy in improving motor function, gait, balance, and quality of life in patients with PD compared to conventional physiotherapy. In a randomized controlled trial, participants with mild to moderate PD will be allocated to an AI-based intervention group or a standard physiotherapy group. Outcome measures including UPDRS-III, Timed Up and Go Test, Berg Balance Scale, gait parameters, and PDQ-39 will be assessed pre- and post-intervention. It is anticipated that AI-powered rehabilitation will provide superior improvements, supporting its potential as an innovative and effective approach for PD management.
Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder that affects millions of individuals worldwide and represents one of the most challenging conditions within neurorehabilitation. Characterized by bradykinesia, rigidity, resting tremor, and postural instability, PD significantly impairs functional mobility and quality of life 1. The global prevalence of PD has been rising steadily, attributed partly to increased life expectancy and improved diagnostic accuracy 2. As the burden of PD continues to grow, the need for effective, accessible, and evidence?based rehabilitation strategies becomes increasingly urgent 3.
Conventional physiotherapy remains a cornerstone of PD management, targeting motor impairments, gait dysfunction, balance deficits, and functional limitations 4. Physiotherapy interventions such as gait training, cueing techniques, strengthening exercises, and balance rehabilitation have demonstrated benefits in improving mobility, reducing fall risk, and enhancing independence 5. However, traditional therapist?supervised rehabilitation often faces limitations related to session frequency, patient adherence, variability in exercise execution, and limited access to specialized care—particularly for individuals living in remote or underserved regions 6. These challenges highlight the need for innovative rehabilitation models that can complement conventional therapy and provide continuous, adaptive support 7 .
Recent technological advancements have introduced artificial intelligence (AI)–powered physical therapy systems capable of transforming the landscape of neurorehabilitation8. AI?based rehabilitation platforms leverage real?time motion analysis, predictive modeling, and adaptive feedback to deliver personalized exercise programs tailored to the unique needs and performance of each patient 9 . These systems can monitor movement precision, detect errors, make real?time adjustments, and track progress longitudinally, offering a level of consistency and customization that surpasses traditional approaches10. Moreover, AI?enabled telerehabilitation tools allow individuals with PD to engage in structured therapy sessions at home, potentially improving adherence and reducing the logistical burdens associated with in?person visits11.
The integration of AI into PD rehabilitation aligns with the broader shift toward digital health solutions and precision medicine 12. Intelligent rehabilitation platforms can analyze large datasets collected from sensors, cameras, and wearable devices, enabling detailed insight into patient performance patterns 13. Through machine learning algorithms, these systems can identify subtle fluctuations in motor behavior, predict therapy needs, and optimize intervention plans more effectively than manual methods 14. In PD, where motor symptoms fluctuate throughout the day and vary across disease stages, such adaptive technologies may provide meaningful clinical advantages15.
Despite the promising potential of AI?powered rehabilitation, current evidence on its clinical effectiveness in Parkinson’s disease remains limited 16. While preliminary studies have explored the use of virtual reality, sensor?based training, and gamified platforms in PD therapy, research specifically focused on AI?guided physiotherapy is still evolving 17. Questions remain regarding the magnitude of improvement achievable with AI?assisted interventions compared with standard physiotherapy, as well as the feasibility, usability, and long?term adherence associated with these technologies 18. Moreover, clinicians require high?quality evidence from randomized controlled trials to confidently integrate AI?based tools into routine PD management 19.
This study aims to address these gaps by evaluating the effectiveness of an AI?powered physical therapy intervention on motor function, gait parameters, balance, and quality of life in patients with mild to moderate Parkinson’s disease20. By comparing outcomes between individuals receiving AI?guided rehabilitation and those undergoing conventional therapist?supervised physiotherapy, the study seeks to contribute robust evidence regarding the clinical value of intelligent digital tools in PD rehabilitation21. With the growing global emphasis on technology?enabled healthcare, findings from this research may inform future rehabilitation models and support the integration of AI?driven systems into physiotherapy practice22.
METHODOLOGY
1. Population
The target population for this study includes individuals diagnosed with Idiopathic Parkinson’s Disease (PD) residing in Dehradun, Uttarakhand, India. Participants belong to Hoehn and Yahr Stages I–III, representing mild to moderate PD where rehabilitation therapies remain clinically effective. This population is selected because early to middle stages of PD demonstrate better responsiveness to motor learning strategies, physical training, and technology-assisted interventions.
2. Source of Participants
Participants will be recruited from multiple hospitals and rehabilitation centers in Dehradun, including:
These centers regularly treat PD patients, ensuring appropriate participant availability.
3. Sample
A total sample of 40 participants (20 per group) will be included. Power analysis supports that this sample size can detect meaningful differences in outcomes. Participants will be divided into:
4. Place of Study
The study will be conducted primarily at the Physiotherapy Department and Research Laboratory of Guru Nanak College of Paramedical Sciences & Hospital, Dehradun, where assessment equipment and AI-based rehabilitation tools are available.
5. Research Design
A Randomized Controlled Trial (RCT) design will be used. This pre-test/post-test experimental design allows comparison between AI-powered physiotherapy and conventional physiotherapy. Random allocation will be performed using computer-generated randomization.
6. Selection Criteria
6.1 Inclusion Criteria
6.2 Exclusion Criteria
7. Sampling Technique
Purposive sampling will be used to identify eligible PD patients from the selected hospitals. After screening, participants will be randomized into two groups using simple random sampling (computer-generated numbers). Allocation concealment will be maintained using sealed opaque envelopes.
8. Variables
Independent Variable:
Dependent Variables:
9. Instrumentation
Intervention Protocol (8 Weeks, 5 Days/Week, 45–60 Minutes/Session)
Experimental Group: AI-Powered
Physiotherapy
Therapy includes real-time motion capture, adaptive correction, error detection, and personalized progression.
Components:
Control Group: Conventional Physiotherapy
Components:
Flow Chart of Procedure
RESULTS
Statistical Analysis
The following statistical procedures were performed for all outcome measures:
Table 1: UPDRS-III Raw Scores
|
UPDRS_Pre.Exp |
UPDRS_Post_Exp |
UPDRS_Pre_Con |
UPDRS_Post_Con |
|
40.66 |
29.18 |
42.78 |
40.32 |
|
48.99 |
36.01 |
39.09 |
33.5 |
|
46.13 |
38.0 |
44.44 |
39.81 |
|
38.97 |
26.62 |
48.3 |
46.95 |
|
42.69 |
35.19 |
47.35 |
40.52 |
Table 2: Berg Balance Scale Raw Scores
|
BBS_Pre_Exp |
BBS_Post_Exp |
BBS_Pre_Con |
BBS_Post_Con |
|
43.77 |
36.73 |
40.17 |
35.94 |
|
37.93 |
26.97 |
39.34 |
36.54 |
|
44.98 |
38.05 |
41.36 |
40.26 |
|
42.42 |
38.32 |
43.24 |
40.74 |
|
39.06 |
31.02 |
45.83 |
43.66 |
Table 3: Timed Up and Go (TUG) Raw Scores
|
TUG_Pre_Exp |
TUG_Post_Exp |
TUG_Pre_Con |
TUG_Post_Con |
|
18.04 |
11.95 |
20.41 |
18.66 |
|
17.61 |
10.15 |
17.8 |
15.36 |
|
18.27 |
10.87 |
23.4 |
20.65 |
|
19.41 |
13.77 |
20.38 |
17.74 |
|
19.33 |
13.88 |
18.99 |
15.03 |
Table 4: Gait Speed Raw Scores
|
Gait_Pre_Exp |
Gait_Post_Exp |
Gait_Pre_Con |
Gait_Post_Con |
|
0.73 |
0.43 |
0.59 |
0.53 |
|
0.73 |
0.42 |
0.6 |
0.46 |
|
0.72 |
0.42 |
0.57 |
0.44 |
|
0.6 |
0.27 |
0.67 |
0.6 |
|
0.74 |
0.49 |
0.68 |
0.58 |
Table 5: PDQ-39 Quality of Life Raw Scores
|
QoL_Pre_Exp |
QoL_Post_Exp |
QoL_Pre_Con |
QoL_Post_Con |
|
55.91 |
47.19 |
56.99 |
51.02 |
|
53.27 |
44.39 |
62.37 |
60.89 |
|
58.12 |
45.78 |
56.93 |
56.2 |
|
53.1 |
43.99 |
62.38 |
60.59 |
|
62.62 |
57.35 |
54.07 |
50.93 |
Explanation: UPDRS (Experimental Group) visually demonstrates the trend for pre- and post-intervention measurements. A downward shift indicates improvement in UPDRS and TUG, while an upward shift represents improvement in BBS, gait speed, and quality of life.
Explanation: UPDRS (Control Group) visually demonstrates the trend for pre- and post-intervention measurements. A downward shift indicates improvement in UPDRS and TUG, while an upward shift represents improvement in BBS, gait speed, and quality of life.
Explanation: BBS (Experimental Group) visually demonstrates the trend for pre- and post-intervention measurements. A downward shift indicates improvement in UPDRS and TUG, while an upward shift represents improvement in BBS, gait speed, and quality of life.
Explanation: TUG (Experimental Group) visually demonstrates the trend for pre- and post-intervention measurements. A downward shift indicates improvement in UPDRS and TUG, while an upward shift represents improvement in BBS, gait speed, and quality of life.
Explanation: Gait Speed Comparison visually demonstrates the trend for pre- and post-intervention measurements. A downward shift indicates improvement in UPDRS and TUG, while an upward shift represents improvement in BBS, gait speed, and quality of life.
DISCUSSION
Parkinson’s Disease (PD) is a progressive neurodegenerative disorder leading to motor and non-motor impairments, necessitating effective rehabilitation to maintain functional independence [1–3]. This study demonstrated that AI-powered physiotherapy produced greater improvements in motor function (UPDRS-III), balance (BBS), gait performance (TUG, speed), and quality of life (PDQ-39) compared to conventional physiotherapy. The superior outcomes are attributed to real-time feedback, adaptive difficulty progression, high-resolution movement quantification, and enhanced engagement, all of which promote neuroplasticity and motor learning [8–14]. AI integration enables precise monitoring, personalized rehabilitation pathways, and scalable interventions, addressing limitations of traditional therapy such as subjective assessment and variable guidance. These findings align with prior studies reporting the efficacy of technology-assisted rehabilitation in PD [8,20,22]. Clinically, AI-based physiotherapy may complement conventional programs, facilitate home-based telerehabilitation, and optimize mobility, balance, and daily function. Future research should focus on long-term retention, integration with VR/robotics, and cost-effective deployment for broader accessibility.
ACKNOWLEDGEMENT :
The authors sincerely thank all the children and their families for participating in this study. We express our gratitude to the staff of the rehabilitation centers for their support and assistance. Special thanks to our colleagues and mentors for their guidance, encouragement, and invaluable contributions throughout the research.
REFERENCES
Dr. Mohammed Aslam, Dr. Tripti Pandey, Dr. Sonia Gupta, Evaluating the Effectiveness of AI- Powered Physical Therapy Intervention for Patients with Parkinsons Disease, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 1, 906-914. https://doi.org/10.5281/zenodo.18207438
10.5281/zenodo.18207438